These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15428294)

  • 1. Use of ergot preparations in migraine.
    FUCHS M; BLUMENTHAL LS
    J Am Med Assoc; 1950 Aug; 143(17):1462-4. PubMed ID: 15428294
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of ergot-caffeine suppositories in migraine.
    BLUMENTHAL LS; FUCHS M
    Med Ann Dist Columbia; 1950 Feb; 19(2):77-9. PubMed ID: 15410166
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of ergot drugs for migraine.
    FUCHS M; BLUMENTAL LS
    Med Ann Dist Columbia; 1952 Jul; 21(7):372-5. PubMed ID: 14940113
    [No Abstract]   [Full Text] [Related]  

  • 4. [The dihydroergotamine in the treatment of the migraine headache].
    BRUSSELMANS P
    Belg Tijdschr Geneesk; 1948 Aug; 4(15):721. PubMed ID: 18886638
    [No Abstract]   [Full Text] [Related]  

  • 5. Historical development of the ergot therapy of migraine.
    ROTHLIN E
    Int Arch Allergy Appl Immunol; 1955; 7(4-6):205-9. PubMed ID: 13306339
    [No Abstract]   [Full Text] [Related]  

  • 6. Further experience with dihydroergotamine methanesulfonate in the treatment of migraine; with a note on the use of cafergone.
    POLLOCK LA
    Ann West Med Surg; 1949 Nov; 3(11):388-90. PubMed ID: 15407298
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of caffeinated ergotamine tartrate in migraine attacks; E. C. 110 or cafergon; first results].
    GIRARD M
    J Med Chir Prat; 1950 Aug; 121(8):165-9. PubMed ID: 24538126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results].
    GIRARD M
    Lyon Med; 1950 May; 183(22):345-8. PubMed ID: 15438042
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydroergotamine in the treatment of migraine; preliminary clinical observations.
    FRIEDMAN MD; FRIEDMAN DA
    Ohio State Med J; 1945; 41():1099. PubMed ID: 21003955
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
    DANNENBERG T
    Perm Found Med Bull; 1946 Jul; 4():96-103. PubMed ID: 20987521
    [No Abstract]   [Full Text] [Related]  

  • 11. D.H.E. 45 (dihydroergotamine) in the treatment of allergic megraine.
    CLEIN NW
    Ann Allergy; 1946; 4():128-30. PubMed ID: 21028269
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of the temperature on alkaloids in ergot].
    HUBIK J
    Cas Cesk Lek; 1950; 63(7-8):89-105. PubMed ID: 14792569
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical observations on the hypotensive effect of certain dihydrogenated alkaloids of ergot in human beings.
    JOSEPHS IL
    Am Pract Dig Treat; 1949 Oct; 4(2):71-4. PubMed ID: 18142547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Production of ergot (Claviceps purpurea T.) in Croatia].
    DIM-ZAJEC V; MASTNAK A
    Farm Glas; 1951 Feb; 7(2):44-51. PubMed ID: 14823013
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorimetric assays of ergot and ergot fluidextract with added precautions.
    MAURINA FA
    Bull Am Pharm Assoc; 1948; 16(1-2):43-8. PubMed ID: 18911823
    [No Abstract]   [Full Text] [Related]  

  • 16. Revised colorimetric assays of ergot and ergot fluidextract.
    MAURINA FA
    Bull Am Pharm Assoc; 1948; 16(1-2):22-6. PubMed ID: 18911821
    [No Abstract]   [Full Text] [Related]  

  • 17. The excessive use of ergot.
    BLUMENTHAL LS; FUCHS M
    Am Pract Dig Treat; 1959 Sep; 10():1502-6. PubMed ID: 13801747
    [No Abstract]   [Full Text] [Related]  

  • 18. [The scientific basis of new drugs; Ergot preparations].
    THER L
    Suddeutsch Apoth Ztg; 1948 Oct; 88(12):327-9. PubMed ID: 18128916
    [No Abstract]   [Full Text] [Related]  

  • 19. Report on the development of new methods in the colorimetric assay of ergot and ergot fluidextract.
    MAURINA FA
    Bull Am Pharm Assoc; 1948; 16(1-2):27-43. PubMed ID: 18911822
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental and clinical studies of the dihydrogenated alkaloids of ergot of rye].
    SCHNEIDER PB
    Schweiz Arch Neurol Psychiatr; 1950; 65(1-2):283-310. PubMed ID: 15430992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.